Ovulatory premenopausal women lose cancellous spinal bone: A five year prospective study
article
OA: closed
CC0
⤵ 2 in-corpus citations
AI-generated summary
This five-year prospective study found that premenopausal women experience a loss of cancellous spinal bone.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Healthy premenopausal women with regular cycles are believed to be increasing or maintaining bone density. However, few studies have prospectively documented spinal cancellous bone, the bone that changes rapidly in response to reproductive hormones, in this population. Furthermore, our previous one-year study documented that 24% of the one-year bone change by quantitative computed tomography (QCT) was related to subclinical ovulatory disturbances (short luteal phase and non-ovulation) in the presence of regular menstrual cycles. The purpose of this study was to document the cancellous bone change over five years in this initially ovulatory, premenopausal cohort of 66 healthy women. Thirty-seven women, who continued to be premenopausal and have regular cycles, completed this five-year study. Those enrolled differed only by being older and weighing less than those who could not be contacted (n = 19) or who declined to participate (n = 10). Documentation of current ovulatory characteristics was obtained for at least three cycles in 27 women. At the five-year assessment, the volunteers were 40.6 (range 26-47) years old, weighed 58.5 (41-77) kg, and were 160.9 (149-174) cm in height. All were premenopausal, healthy, nonsmokers with regular menstrual cycles (mean 27.7, range 24-33 days). Six women with intervening events (such as pregnancy or use of oral contraceptives) had interval (12 to 60 months) QCT changes similar to the remaining 31 (-7.98 vs. -4.92 mg/cm, p = 0.1, respectively). Mean five-year QCT was 143.0 +/- 20.2 mg/cm, whereas the initial mean value was 151.9 +/- 20.1 mg/cm. Significant QCT loss over five years (-8.9 +/- 6.2 mg/cm) (95% Cl -6.9 to -11.0) correlated with QCT change in the first year (r = 0.629, p < 0.001). First-year change was not related to the subsequent four-year interval change (r = -0.056, p = 0.74), however. Five-year QCT change was not related to age, weight, osteoporosis family history, estimated calcium intake, or exercise, but did correlate with year one luteal index (luteal/cycle length) (r = 0.339, p = 0.043). Significant cancellous spinal bone loss occurs in healthy, ovulatory premenopausal women, and is influenced by subclinical disturbances of ovulation.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
Cited by (2)
References (38)
- Cyclic medroxyprogesterone treatment increases bone density: A controlled trial in active women with menstrual cycle disturbances via openalex
- W177707415 via openalex
- W368475356 via openalex
- W1826435893 via openalex
- W1975184549 via openalex
- W1984269259 via openalex
- W1987028578 via openalex
- W2002924549 via openalex
- W2005369718 via openalex
- W2011790043 via openalex
- W2015950286 via openalex
- W2040395479 via openalex
- W2051532007 via openalex
- W2058699721 via openalex
- W2061958057 via openalex
- W2068865027 via openalex
- W2072101080 via openalex
- W2082351657 via openalex
- W2094135154 via openalex
- W2102938019 via openalex
- W2103131871 via openalex
- W2147380647 via openalex
- W2148282837 via openalex
- W2156600737 via openalex
- W2403075119 via openalex
- W2411694298 via openalex
- W2415553976 via openalex
- W2797588280 via openalex
- W2806833083 via openalex
- W3122470341 via openalex
- W4246132361 via openalex
- W4246543253 via openalex
- W6607222871 via openalex
- W6665154031 via openalex
- W6667702912 via openalex
- W6713397778 via openalex
- W152785794 via openalex
- W6752250580 via openalex
Cited by (2)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-08-29T06:28:44.313744+00:00
License: CC0
· commercial use OK